DSD-C124

Other / unspecified DSD · 46,XY · DSD-C124

DSD-C124 · Other / unspecified DSD · 1989

Genes AR · Karyotype 46,XY · Phenotypes HPO:0000047, HPO:0000054, Micropenis (HP:0000054), Hypospadias (HP:0000047)

Androgen resistance syndrome — partial male pseudohermaphroditism due to a qualitative androgen receptor defect. This case is unique in showing a marked response to high-dose androgen therapy (overcoming receptor dysfunction).

Images · 2

Case fields and evidence

Category

Other / unspecified DSD

Age

Infancy at initial presentation → followed up to 4 years

Sex

Assigned female at birth, switched to male rearing at 5 days (testes palpable within labioscrotal folds)

Karyotype

46,XY

Phenotypes

Micropenis (HP:0000054); Hypospadias (HP:0000047)

Diagnosis

Androgen resistance syndrome — partial male pseudohermaphroditism due to a qualitative androgen receptor defect. This case is unique in showing a marked response to high-dose androgen therapy (overcoming receptor dysfunction).

Follow-up

At 4 years, height 101 cm (50th percentile). Close monitoring of pubertal virilization.

General phenotype

Generally normal apart from genitalia; after high-dose testosterone, sparse limb and upper-lip hair, mild axillary hyperpigmentation, and slight breast enlargement appeared (resolved within 3 months of discontinuation).

Imaging

No imaging abnormality reported.

Laboratory findings

Testosterone pre-hCG: 0.5 nmol/L (reference: low; time point: infancy); testosterone post-hCG: 5.1 nmol/L (reference: normal for age; time point: infancy, hCG 1000 U/d ×3 d); DHT (post-hCG): 0.89 nmol/L (reference: normal; time point: post-hCG); AR binding capacity (monolayer): 24.1 fmol/mg protein (reference: normal 15–30; time point: fibroblast culture); temperature sensitivity (30→41°C): binding decreased by 60% (reference: controls <20%; time point: key diagnostic indicator); ligand dissociation rate: accelerated 5-fold (reference: normal 50% requires 4–5 h vs proband 50 min; time point: key diagnostic indicator)

Management

At 12 months, low-dose testosterone (50 mg q4w ×2) was ineffective → female rearing recommended. At 2.5 and 3.5 years, high-dose testosterone cypionate (100 mg q2w ×6 per course) for 2 courses yielded marked penile growth. At 4 years, left orchidopexy was performed, and in July 1988 a successful single-stage hypospadias repair.

Pathology

Gonadal biopsy pathology not reported (testes palpable and functional).

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Other / unspecified DSD · 46,XY · DSD-C124 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C124?version=v1.4.0